The American Psychiatric Association recommends that patients receiving antipsychotic medication be evaluated approximately every 3 months for signs of tardive dyskinesia.2 The risk of tardive dyskinesia is significantly less but not completely eliminated, with atypical antipsychotic agents.1,3 Symptoms of tardive dyskinesia may not resolve when the antipsychotic agent is stopped.2 All patients should be monitored regardless of whether there is a prior history of tardive dyskinesia.
- Approximately every 3 months.
1. Sadock BJ, Sadock VA. Biological therapies. In: Synopsis of psychiatry. Philadelphia: Lippincott, Williams & Wilkins; 2003:505-1150.
2. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. 2nd ed. American Psychiatric Association practice guidelines for the treatment of psychiatric disorders compendium 2002. Washington (DC): The Association; 2002:349-461.
3. Kane JM. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. J Clin Psychiatry 2004;65(Suppl 9):16-20.
Click here to return to the questions
Seminars in Medical Practice
Hospital Physician Board Review Manuals
Copyright © 2009, Turner White Communications
Updated 4/6/07 kkj